\n<\/p>\n
Indian shares were flat to slightly lower on Thursday, tracking weak global markets<\/span> after the July FOMC meeting minutes suggested continuation of the hawkish stance to bring inflation under control. <\/p>\n The benchmark S&P BSE Sensex slipped 15 points to 60,245 in early trade, while the broader NSE Nifty index was down 7 points at 17,937.<\/p>\n Pharma stocks succumbed to selling pressure, with Cipla, Sun Pharma and Dr Reddy’s Laboratories losing 1-3 percent. <\/p>\n Wipro fell 1.3 percent after reports that it has decided to pause variable pay-outs for the April-June quarter for mid and senior-level employees amid significant pressure on margins.<\/p>\n Financials traded higher, with SBI, HDFC Life, Kotak Mahindra Bank and SBI Life rallying 1-2 percent.<\/p>\n Bharti Airtel and Vodafone Idea were seeing modest gains after the release of monthly subscriber data by TRAI.<\/p>\n Natco Pharma gained 2 percent after it received tentative approval from the U.S. FDA for Trabectedin for injection. <\/p>\n Infibeam Avenues surged 6.3 percent on fund raising reports. <\/p>\n GAIL rose 0.6 percent. The company’s board approved plans to raise $3.125 billion via external commercial borrowing and up to Rs 25,000 crore via non-convertible debentures.<\/p>\n ONGC was marginally lower after in inked an agreement with global oil giant ExxonMobil Corp for deepwater exploration in India. <\/p>\n Adani Green Energy edged up slightly. The company has received provisional approval from Sri Lanka for two wind projects.<\/p>\n Yes Bank gained 0.6 percent after it became a limited partner (LP) in two Venture Catalysts Group funds by investing an undisclosed amount. <\/p>\n<\/p>\n Market Analysis<\/p>\n<\/div>\n